276 related articles for article (PubMed ID: 24889234)
21. The vaccinia virus A38L gene product is a 33-kDa integral membrane glycoprotein.
Parkinson JE; Sanderson CM; Smith GL
Virology; 1995 Dec; 214(1):177-88. PubMed ID: 8525613
[TBL] [Abstract][Full Text] [Related]
22. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response.
Brandt T; Heck MC; Vijaysri S; Jentarra GM; Cameron JM; Jacobs BL
Virology; 2005 Mar; 333(2):263-70. PubMed ID: 15721360
[TBL] [Abstract][Full Text] [Related]
23. The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model.
Symons JA; Adams E; Tscharke DC; Reading PC; Waldmann H; Smith GL
J Gen Virol; 2002 Nov; 83(Pt 11):2833-2844. PubMed ID: 12388820
[TBL] [Abstract][Full Text] [Related]
24. Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence.
Fahy AS; Clark RH; Glyde EF; Smith GL
J Gen Virol; 2008 Oct; 89(Pt 10):2377-2387. PubMed ID: 18796705
[TBL] [Abstract][Full Text] [Related]
25. Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence.
Reading PC; Khanna A; Smith GL
Virology; 2002 Jan; 292(2):285-98. PubMed ID: 11878931
[TBL] [Abstract][Full Text] [Related]
26. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.
Meyer H; Sutter G; Mayr A
J Gen Virol; 1991 May; 72 ( Pt 5)():1031-8. PubMed ID: 2033387
[TBL] [Abstract][Full Text] [Related]
27. Vaccinia virus gene B7R encodes an 18-kDa protein that is resident in the endoplasmic reticulum and affects virus virulence.
Price N; Tscharke DC; Hollinshead M; Smith GL
Virology; 2000 Feb; 267(1):65-79. PubMed ID: 10648184
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Translation Initiation by Protein 169: A Vaccinia Virus Strategy to Suppress Innate and Adaptive Immunity and Alter Virus Virulence.
Strnadova P; Ren H; Valentine R; Mazzon M; Sweeney TR; Brierley I; Smith GL
PLoS Pathog; 2015 Sep; 11(9):e1005151. PubMed ID: 26334635
[TBL] [Abstract][Full Text] [Related]
29. Redundancy complicates the definition of essential genes for vaccinia virus.
Dobson BM; Tscharke DC
J Gen Virol; 2015 Nov; 96(11):3326-3337. PubMed ID: 26290187
[TBL] [Abstract][Full Text] [Related]
30. Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread.
Luker KE; Hutchens M; Schultz T; Pekosz A; Luker GD
Virology; 2005 Oct; 341(2):284-300. PubMed ID: 16095645
[TBL] [Abstract][Full Text] [Related]
31. Vaccinia virus-induced smallpox postvaccinal encephalitis in case of blood-brain barrier damage.
Garcel A; Fauquette W; Dehouck MP; Crance JM; Favier AL
Vaccine; 2012 Feb; 30(7):1397-405. PubMed ID: 22227123
[TBL] [Abstract][Full Text] [Related]
32. Vaccinia virus Western Reserve induces rapid surface expression of a host molecule detected by the antibody 4C7 that is distinct from CLEC2D.
Williams KJ; Eaton HE; Jones L; Rengan S; Burshtyn DN
Microbiol Immunol; 2016 Nov; 60(11):754-769. PubMed ID: 27862195
[TBL] [Abstract][Full Text] [Related]
33. Initial characterization of vaccinia virus B4 suggests a role in virus spread.
Burles K; Irwin CR; Burton RL; Schriewer J; Evans DH; Buller RM; Barry M
Virology; 2014 May; 456-457():108-20. PubMed ID: 24889230
[TBL] [Abstract][Full Text] [Related]
34. A Model to Detect Autochthonous Group 1 and 2 Brazilian Vaccinia virus Coinfections: Development of a qPCR Tool for Diagnosis and Pathogenesis Studies.
Calixto R; Oliveira G; Lima M; Andrade AC; Trindade GS; de Oliveira DB; Kroon EG
Viruses; 2017 Dec; 10(1):. PubMed ID: 29301202
[No Abstract] [Full Text] [Related]
35. Assessing the variability of Brazilian Vaccinia virus isolates from a horse exanthematic lesion: coinfection with distinct viruses.
Campos RK; Brum MC; Nogueira CE; Drumond BP; Alves PA; Siqueira-Lima L; Assis FL; Trindade GS; Bonjardim CA; Ferreira PC; Weiblen R; Flores EF; Kroon EG; Abrahão JS
Arch Virol; 2011 Feb; 156(2):275-83. PubMed ID: 21080203
[TBL] [Abstract][Full Text] [Related]
36. Filamin B restricts vaccinia virus spread and is targeted by vaccinia virus protein C4.
Georgana I; Scutts SR; Gao C; Lu Y; Torres AA; Ren H; Emmott E; Men J; Oei K; Smith GL
J Virol; 2024 Mar; 98(3):e0148523. PubMed ID: 38412044
[TBL] [Abstract][Full Text] [Related]
37. Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.
Peng C; Moss B
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3759-3767. PubMed ID: 32019881
[TBL] [Abstract][Full Text] [Related]
38. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
[TBL] [Abstract][Full Text] [Related]
39. Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes.
Tscharke DC; Reading PC; Smith GL
J Gen Virol; 2002 Aug; 83(Pt 8):1977-1986. PubMed ID: 12124461
[TBL] [Abstract][Full Text] [Related]
40. Protection against lethal vaccinia virus infection in mice using an siRNA targeting the A5R gene.
Seo D; Kim NY; Lee JA; Han KR; Hur GH; Yang JM; Shin S
Antivir Ther; 2016; 21(5):397-404. PubMed ID: 26741698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
